Dr. Patrick Yang is one of the most accomplished biotech manufacturing executives and technical operations leaders in the industry.

Most recently, Pat was the Executive Vice President and special advisor for Juno Therapeutics. Previously, he was Executive Vice President and Global Head of Technical Operations at Roche and was responsible for the company’s pharmaceutical process development, engineering, quality, technical regulatory, supply chain, and all manufacturing plants. Prior to that, he was Executive Vice President of Product Operations of Genentech, Inc. Patrick served for 11 years at Merck & Company in various leadership positions including Vice President of Asia Pacific operations and Vice President of Global Supply Chain management. Prior to joining Merck, Pat spent 12 years at General Electric serving in several research, engineering, technology, and manufacturing leadership roles with increasing scope of responsibilities.

Pat earned his B.S. from the National Chiaotung University in Taiwan, his M.S. from the University of Cincinnati, and his Ph.D. in engineering from Ohio State University.

Pat is a board member of Sana Biotechnology, Inc., Codexis, Amyris and PharmaEssentia. He serves as Chairman of AbGenomics, Acepodia and Aerchigen Biotech.